Page 55

presence with a new state-of-the-art warehouse facility at its compound in Phnom Penh, Cambodia. The new facility represents a bold step towards capturing this youthful, increasingly health-conscious market on the eve of ASEAN integration. The temperature-controlled warehouse of over 25,000 sq. feet incorporates cold storage facilities and is served by a fleet of temperature-controlled delivery vehicles. Mega’s local team of more than 200 dedicated and passionate Cambodians handles more than 600 stock keeping units equipped with specialized Enterprise Resource Planning (ERP) software for accounting, reporting and information sharing. Mr. Vivek Dhawan, CEO and Chief Coach of Mega Lifesciences, commented on the occasion of the opening that, “This warehouse represents a new chapter for Mega Lifesciences in Cambodia and throughout this region. Equipped with new ERP software and with Samsung Galaxy Tabs used to manage the sales cycle, this facility not only meets the highest international warehousing standards, but is also imparting key technical skills to Mega’s local staff, part of our core philosophy of Creating Shared Value for each of the communities we work in.” Mr. Dhawan emphasized that Mega being an ISO 9001:2008 certified company will implement Good Distribution and Storage Practices as per international guidelines. Department of Drugs and Food Director Dr. Heng Bunkiet, who was the guest of honour at the opening, commented that, “We are delighted that Mega Lifesciences is choosing Cambodia for this major investment. Mega has been an outstanding partner for Cambodia since their entry here in 1996 in terms of creating value and employment while promoting good health, and we at DDF and the Ministry of Health look forward to further deepening that relationship as we approach ASEAN economic integration.” The facility will serve both Mega’s branded business as well as the Maxxcare distribution business, which currently operates in Cambodia, Vietnam and Myanmar. With a distribution network covering all of Cambodia’s 25 provinces, Mega was among the first to provide regular nationwide coverage in the country. Mega Lifesciences Cambodia Country Manager Mr. Narendra Kumar commented that, “Cambodia has one of the youngest populations in the region, coupled with an extremely stable and growing economy. With increasing awareness of good health and rising income levels here, and the approaching prospect of ASEAN integration, Cambodia will be an increasingly key market for us. With that in mind, we’re investing in the infrastructure to meet that growth, while reaffirming Mega’s commitment to provide customers with quality products and constant improvement in services.” Mega Lifesciences is a leading Thai nutritional, herbal, over-the-counter, and prescription pharmaceutical company engaged in manufacturing, marketing, selling and distributing medicines in emerging markets including Myanmar, Cambodia,

Vietnam, Philippines, Indonesia, Malaysia and Singapore. Since its initial public offering on the Stock Exchange of Thailand in November 2013, it is the only company in Thailand to offer investors exposure to high-growth healthcare and pharmaceutical markets outside of Thailand, including ASEAN, Eastern Europe, the Middle East and Africa. About Mega Lifesciences Public Company Limited Mega Lifesciences Public Company Limited manufactures, markets, sells and distributes high-quality medicines including nutritional supplements and pharmaceuticals in emerging markets internationally. Mega Lifesciences is focused on servicing fastgrowing, developing markets, with its branded products being sold in a total of 31 countries around the globe. Mega Lifesciences is composed of two main divisions: Mega We Care, which focuses on manufacturing, sales and marketing; and Maxxcare, which focuses on distribution. Mega Lifesciences’ manufacturing facilities have received international accreditation from the Therapeutic Goods Administration of Australia and the Federal Institute for Drugs and Medical Devices (BfArM - Germany), as well as adhering to European Union Good Manufacturing Practices. Mega Lifesciences is listed on the Stock Exchange of Thailand (SET) under the ticker symbol ‘MEGA’. News info Hill+Knowlton Strategies - Mar 16, 2015

แวคเกอร์ตั้งโรงงานผลิตโพลีไวนิลอะซีเตทในจีน

บริษัท แวคเกอร์เคมมี เอจี เปิดตัวโรงงานผลิตโพลีไวนิลอะซี เตท (PVAc) เกรดสำ�หรับอาหารในเมืองนานกิง (จังหวัดเจียงสู) ประเทศจีน มีกำ�ลังการผลิต 20,000 ตันต่อปี จึงนับเป็นโรงงานที่ ใหญ่ทสี่ ดุ ในเอเชียของบริษทั และได้รบั การรับรองมาตรฐานอาหาร ระดับสูงสุด เรซิน PVAc แบบของแข็ง ใช้เป็นกัมในการผลิตหมาก ฝรัง่ แวคเกอร์ลงทุนครัง้ นีเ้ พือ่ รับประกันปริมาณผลผลิตทีเ่ พียงพอ ต่อความต้องการเรซิน PVAc แบบของแข็งในระยะยาว และมอบ ความมั่นคงด้านวัตถุดิบและคุณภาพของผลิตภัณฑ์ให้กับลูกค้าใน ภูมิภาคเอเชียแปซิฟิก บริษัทได้ลงทุนในโครงการขยายการผลิต ประมาณ 20 ล้านยูโร ทำ�ให้แวคเกอร์เป็นผู้นำ�ในการผลิตเรซิน Mar-Apr

55

INNOLAB magazine #739  
INNOLAB magazine #739  
Advertisement